Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

2019232 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 7, Issue 9, pp. 780-790

Field-Weighted Citation Impact: 16.50